257 related articles for article (PubMed ID: 15217566)
1. [In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].
de Mouzon J; Allavena E; Schmitt C; Frappé M
Gynecol Obstet Fertil; 2004 Jun; 32(6):508-18. PubMed ID: 15217566
[TBL] [Abstract][Full Text] [Related]
2. Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness.
Gerli S; Casini ML; Unfer V; Costabile L; Bini V; Di Renzo GC
Fertil Steril; 2004 Sep; 82(3):573-8. PubMed ID: 15374698
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
[TBL] [Abstract][Full Text] [Related]
4. [Health economic consequences of the choice of follicle stimulating hormone alternatives in IVF treatment].
Poulsen PB; Højgaard A; Quartarolo JP
Ugeskr Laeger; 2007 Apr; 169(14):1313-7. PubMed ID: 17437694
[TBL] [Abstract][Full Text] [Related]
5. FSH: urinary and recombinant.
Palagiano A; Nesti E; Pace L
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115 Suppl 1():S30-3. PubMed ID: 15196713
[TBL] [Abstract][Full Text] [Related]
6. [Ovarian stimulation for IVF in France: choice and results according to protocols and gonadotrophin].
Rossin B; Pouly JL; Belaisch-Allart J; de Mouzon J;
Gynecol Obstet Fertil; 2009; 37(11-12):864-72. PubMed ID: 19833539
[TBL] [Abstract][Full Text] [Related]
7. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
8. Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha.
Wechowski J; Connolly M; Schneider D; McEwan P; Kennedy R
Fertil Steril; 2009 Apr; 91(4):1067-76. PubMed ID: 18339384
[TBL] [Abstract][Full Text] [Related]
9. A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data.
Hatoum HT; Keye WR; Marrs RP; Walton SM; Marshall DC
Fertil Steril; 2005 Mar; 83(3):804-7. PubMed ID: 15749525
[TBL] [Abstract][Full Text] [Related]
10. Cost of assisted reproductive technologies for a health maintenance organization.
Hidlebaugh DA; Thompson IE; Berger MJ
J Reprod Med; 1997 Sep; 42(9):570-4. PubMed ID: 9336753
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
12. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures.
Ruvolo G; Bosco L; Pane A; Morici G; Cittadini E; Roccheri MC
Fertil Steril; 2007 Mar; 87(3):542-6. PubMed ID: 17126339
[TBL] [Abstract][Full Text] [Related]
13. An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome.
van Wely M; Bayram N; van der Veen F; Bossuyt PM
Hum Reprod; 2004 Aug; 19(8):1741-5. PubMed ID: 15166128
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
15. [From theory to clinical practice: recombinant FSH in daily practice].
Kably Ambe A; Barrón Vallejo J; Góngora Rodríguez A; Carballo Mondragón E; Anta Jaén E
Ginecol Obstet Mex; 1999 Aug; 67():408-13. PubMed ID: 10504796
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
[TBL] [Abstract][Full Text] [Related]
18. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint.
Polinder S; Heijnen EM; Macklon NS; Habbema JD; Fauser BJ; Eijkemans MJ
Hum Reprod; 2008 Feb; 23(2):316-23. PubMed ID: 18033807
[TBL] [Abstract][Full Text] [Related]
20. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
